Sivik Global Healthcare LLC Lowers Holdings in Encompass Health Co. (NYSE:EHC)

Sivik Global Healthcare LLC cut its position in shares of Encompass Health Co. (NYSE:EHC) by 10.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 45,000 shares of the company’s stock after selling 5,000 shares during the period. Encompass Health comprises 2.2% of Sivik Global Healthcare LLC’s portfolio, making the stock its 22nd biggest position. Sivik Global Healthcare LLC’s holdings in Encompass Health were worth $4,156,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB grew its stake in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after buying an additional 137 shares during the last quarter. UMB Bank n.a. raised its position in shares of Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC boosted its stake in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after purchasing an additional 140 shares in the last quarter. Avior Wealth Management LLC purchased a new stake in Encompass Health during the 3rd quarter worth approximately $40,000. Finally, Tompkins Financial Corp purchased a new position in shares of Encompass Health in the fourth quarter worth $46,000. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Trading Up 0.4 %

NYSE EHC opened at $95.98 on Thursday. Encompass Health Co. has a 52 week low of $70.83 and a 52 week high of $104.55. The firm has a 50 day moving average of $96.58 and a two-hundred day moving average of $94.58. The stock has a market capitalization of $9.67 billion, a PE ratio of 23.18, a price-to-earnings-growth ratio of 1.13 and a beta of 0.89. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same period in the prior year, the firm posted $0.86 EPS. The business’s quarterly revenue was up 11.9% compared to the same quarter last year. As a group, research analysts expect that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on EHC. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Barclays lifted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Finally, Royal Bank of Canada raised their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.